Clinical Trial Update: A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on ASKB589 assessing safety, tolerability, pharmacokinetics, and antitumor activity in locally advanced or metastatic solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ASKB589

Snippet

Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING